Delivery Order SPE2DB20D2104-SPE2DB25FNBCU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ferric Citrate 210 mg tablets in a quantity of 200 units, with a contract ceiling value of $4,653.89. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,301.19 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. As a child contract, this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count packages) with a contract value of $1,224.62. This non-set-aside, competitively awarded delivery order represents a firm fixed-price procurement scheduled for completion by April 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $6,005.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200 tablets of Ferric Citrate 210 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside award was competitively procured and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ferric citrate is an FDA-approved iron replacement therapy used to treat iron deficiency anemia in patients with chronic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Feraheme 510 mg/17 ml vials valued at $7,744.26 with firm fixed pricing. This non-set-aside competitive award is scheduled for completion by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $2,702.00 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $9,667.42 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract utilizes firm fixed price pricing with a completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this delivery order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $39,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ferric subsulfate solution. Under this order, Amerisourcebergen will deliver 500ml bottles of the requested pharmaceutical product to a location in Conshohocken, Pennsylvania by mid-August to support Department of Defense needs. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract vehicle, Amerisourcebergen routinely fulfills orders for medications and other...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.44 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on September 10, 2025, with completion expected by September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBCUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ferric Citrate 210 mg tablets (200-count supply) on September 22, 2025, with a ceiling value of $1,498.00. This firm fixed price, non-competitive set-aside delivery order is scheduled for completion by September 23, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $1 billion global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare programs worldwide. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through competitively awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/22/25 |